Mar 2, 2026 08:00AM
Feb 25, 2026 07:00AM
Feb 23, 2026 08:00AM
Jan 9, 2026 07:03AM
Jan 9, 2026 07:00AM
Jan 8, 2026 07:00AM
Nov 9, 2025 04:15PM New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
Nov 3, 2025 08:32AM
Nov 3, 2025 08:30AM
Oct 30, 2025 05:38AM
Oct 29, 2025 07:00AM
Oct 27, 2025 08:00AM
Oct 27, 2025 08:00AM
Oct 14, 2025 08:06AM Amarin and HLS to present cardiovascular data at Canadian congress
Oct 14, 2025 08:00AM
Aug 31, 2025 08:30AM
Aug 30, 2025 08:30AM
Aug 30, 2025 08:30AM
Aug 25, 2025 08:00AM
Jul 30, 2025 07:00AM
Jun 24, 2025 07:00AM Amarin (AMRN) Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA in Europe
Jun 24, 2025 07:00AM
May 7, 2025 07:00AM
Mar 31, 2025 08:00AM
Mar 19, 2025 07:33AM
Mar 19, 2025 07:30AM
Mar 19, 2025 07:30AM
Mar 12, 2025 07:00AM Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action 
Mar 12, 2025 07:00AM
Feb 27, 2025 09:00AM
Nov 11, 2024 08:00AM
Oct 30, 2024 04:05PM
Oct 8, 2024 07:00AM
Sep 9, 2024 07:30AM
Aug 22, 2024 08:31AM Amarin Corp. (AMRN): Latest Research Highlighting VASCEPA/VAZKEPA REDUCE-IT Subgroup Data Presented at ESC
Aug 22, 2024 08:30AM
Jul 31, 2024 07:00AM
Jul 8, 2024 07:30AM
Jul 8, 2024 07:30AM
Jul 8, 2024 07:30AM
Jun 24, 2024 04:01PM
May 1, 2024 07:00AM  Amarin Reports First Quarter 2024 Business Update and Financial Results
Apr 24, 2024 02:00PM
Apr 8, 2024 08:01AM
Apr 8, 2024 08:00AM
Apr 6, 2024 03:30PM
Mar 25, 2024 08:00AM
Mar 25, 2024 08:00AM
Feb 29, 2024 07:00AM Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 10, 2024 07:02AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All